Centene Reports Loss, Citing Rising Medical Costs
The managed-care company, which focuses on Medicaid, Affordable Care Act plans and Medicare, withdrew its earnings guidance for 2025 earlier this month, citing rising costs in Medicaid and problems in the ACA business, but analysts had still expected lowered profits for the second quarter.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Newsweek
2 hours ago
- Newsweek
Real Reason Behind Birth Rate Decline
Based on facts, either observed and verified firsthand by the reporter, or reported and verified from knowledgeable sources. Newsweek AI is in beta. Translations may contain inaccuracies—please refer to the original content. Countries all over the world are facing declining birth rates, sparking fears there will one day be more elderly people than working-age people to support them. For example, in the United States, the fertility rate (the average number of children a woman has in her lifetime) is now projected to average 1.6 births per woman over the next three decades, according to the Congressional Budget Office's latest forecast released this year. That is below the replacement rate of 2.1 births per woman required to maintain a stable population without immigration. Financial struggles are often cited as the reason for people having fewer or no children, but recent research has focused on cultural changes. Newsweek has pulled together the main reasons birth rates are declining to build a detailed picture of the issue many governments are trying to tackle. The Real Reason Behind The Birth Rate Decline The Real Reason Behind The Birth Rate Decline Newsweek Illustration/Canva/Getty Financial Worries The 2008 financial crisis and its impact on housing, inflation and pay is generally cited a major contributor to people's decisions to delay having children, to have fewer children or not to have them at all. In June, the United Nations Population Fund (UNFPA) found that 39 percent of the 14,000 people across the 14 countries it surveyed said financial limitations prevented them from having their desired family size. "Young people overwhelmingly report worries and uncertainty about their futures. Many expect to experience worse outcomes than their parents did," the report said. "Their concerns about climate change, economic instability and rising global conflicts will be reflected in the choices they make about raising families." U.S. President Donald Trump's administration has taken steps to try to tackle the concerns, including the White House exploring giving women a "baby bonus" of $5,000, according to an April report in The New York Times. The country could also make childbirth free for privately insured families, with the bipartisan Supporting Healthy Moms and Babies Act, which would designate maternity care as an essential health benefit under the Affordable Care Act, which was introduced in the Senate in May. Family Policies Policies around child care and parental leave come up just as often as financial struggles—and the two are often connected. "Countries that have sustained or moderately increased birth rates—like France or the Nordic nations—have done so by investing in affordable child care, paid parental leave, gender-equal workplaces and housing support," said Poonam Muttreja, executive director of the Population Foundation of India. "These create an enabling environment where people feel secure in having children," she told Newsweek. "Fertility decisions are shaped by long-term confidence, not one-off cash handouts." Similarly, Theodore Cosco, a research fellow at The Oxford Institute of Population Ageing, told Newsweek that "addressing declining birth rates would require comprehensive support mechanisms, such as affordable child care, paid parental leave, health care access and economic stability." Gender Inequality Another linked aspect to this is gender inequality—a cause often stressed by Muttreja. While speaking about the situation in India, where the fertility rate is 1.9, according to World Bank data, she called gender inequality a "critical challenge." "No country has become economically advanced without a substantial participation from women in the economy," she previously told Newsweek. "The burden of caregiving, whether for children or elderly family members, falls disproportionately on women, and policies must enable women to balance work and caregiving effectively." Tomas Sobotka, deputy director of the Vienna Institute of Demography, told Newsweek: "Recent research emphasizes that fertility tends to be higher where gender equality is stronger, and where institutional support helps reduce the cost and complexity of raising children." He cited France and Sweden as examples. While their fertility rates have still plummeted in the past decade (1.66 and 1.45, respectively, according to World Bank data), they are higher than the European Union (1.38). This is "partly thanks to generous family policies with affordable child care, well-paid parental leaves and generous financial benefits to families," he said. "These, together with high levels of gender equality, make it easier especially for the better educated women and couples to achieve the number of children they planned." Cultural Shifts Another major, albeit more difficult to measure, contributor is a shift in cultural values. A new study conducted by academics affiliated with the National Bureau of Economic Research (NBER) published last month found that "short-term changes in income or prices cannot explain the widespread decline" in fertility but rather there has been a "broad reordering of adult priorities with parenthood occupying a diminished role." Authors Melissa Schettini Kearney, an economist from the University of Notre Dame in Indiana, and Phillip B. Levine, an economist from Wellesley College in Massachusetts, found there have been "changes in how much value people place on different life choices, generally reflecting a greater emphasis on personal fulfillment and career." These include the fact that most women in high-income countries now work, while it was previously "reasonable to consider having children as a widespread priority for women." But they do not attribute this to "whether women work at all after they are married or have had their first child" but rather "the tension between a lifetime career and the way motherhood interrupts or alters that lifetime career progression." Kearney and Levine also spoke about changes in preferences in general, citing several surveys they reviewed that showed that more people say having a career they enjoy and close friends is extremely or very important than those who say the same about having children. They also mentioned changes in parenting expectations, with it becoming "more resource- and time-intensive" than before, a reduction in marriages, access to effective contraception, abortion policies, fertility and infertility treatments. These reasons became clear when Newsweek looked at Norway, which is considered a global leader in parental leave and child care policies, with the United Nations International Children's Fund (UNICEF) ranking it among the top countries for family-friendly policies. Norway offers parents 12 months of shared paid leave for birth and an additional year each afterward. It also made kindergarten (similar to a U.S. day care) a statutory right for all children age 1 or older in 2008. Yet, Norway's fertility rate has dropped drastically from 1.98 in 2009 to 1.44 in 2024, according to official figures. The rate for 2023 (1.40) was the lowest recorded fertility rate in the country. Newsweek spoke with several local experts about Norway and all cited recent cultural changes, including lower rates of couple formation for those in their 20s, young adults being more likely to live alone and the demands of modern parenting. What Is The Solution? "The short answer is that there are no easy fixes," Kearney and Levine said in their report. "There is no single policy lever that will reliably boost fertility." Kearney and Levine's main call to action is to "widen our lens" when discussing fertility. "There is still so much more we need to know before we can provide something resembling a definitive answer," they said. "Policies like parental leave, child care subsidies, baby bonuses, etc., are much easier to implement and have the potential to affect fertility more rapidly, if they were effective," Levine told Newsweek. "Changing the social conditions that encourage family formation is more difficult and takes longer to accomplish.
American Military News
3 hours ago
- American Military News
Video/Pic: Trump demands drug companies lower prices
President Donald Trump sent 17 pharmaceutical companies letters on Thursday and demanded that the companies lower prices for Americans. The president warned that the 'unacceptable burden' of prescription drug prices will 'end' with his administration. During a press briefing on Thursday, White House Press Secretary Karoline Leavitt said, 'The president signed an executive order earlier this year to solve the problem of exorbitant pharmaceutical pricing.' 'According to recent data, the prices that Americans have been paying for brand-name drugs are more than three times the price other similarly developed nations pay,' Leavitt added. 'The president is determined to solve this problem and took further action today. He has signed 17 letters to pharmaceutical companies' CEOs.' .@PressSec reads one of the letters sent by @POTUS today to the CEOs of pharmaceutical companies: "Moving forward, the only thing I will accept from drug manufacturers is a commitment that provides American families immediate relief from the vastly inflated drug prices…" — Rapid Response 47 (@RapidResponse47) July 31, 2025 Leavitt also shared the letter Trump wrote to the CEO of Eli Lilly and Company. In the letter, Trump warned Eli Lilly and 16 other pharmaceutical companies that the 'unacceptable burden' of brand-name drugs costing 'up to three times higher on average' for Americans than for citizens of other countries 'ends with my administration.' Trump told the pharmaceutical companies, 'Most proposals the Trump administration has received to resolve this critical issue promised more of the same shifting blame and requesting policy changes that would result in billions of dollars in handouts to industry.' The president added, 'Moving forward, the only thing I will accept from drug manufacturers is a commitment that provides American families immediate relief from the vastly inflated drug prices and an end to the free ride of American innovation by European and other developed nations.' READ MORE: Video: Trump order against 'Big Pharma' aims to reduce drug prices While Trump explained that a collaborative effort to reach 'global pricing parity' would be most effective for pharmaceutical companies, the U.S. government, and U.S. patients, he warned that his administration will 'deploy every tool in our arsenal to protect American families' if pharmaceutical companies refuse to take action. In addition to the letter sent to Eli Lilly and Company, Trump sent letters to AbbVie, Amgen, AstraZeneca, Boehringer Ingelheim, Bristol Myers Squibb, EMD Serono, Genentech, Gilead Sciences, GSK, Johnson and Johnson, Merck, Novo Nordisk, Novartis, Pfizer, Regeneron Pharmaceuticals, and Sanofi. In the letters, Trump gave the companies 60 days to extend 'Most-Favored-Nation' pricing to Medicaid and provide 'full portfolios' of drugs for Medicaid patients, guarantee Most-Favored-Nation pricing for new drugs, negotiate with 'foreign freeloading nations' and return 'increased revenues abroad' to patients in the United States, and allow Americans to directly purchase drugs at Most-Favored-Nation prices. Today, @POTUS sent letters to 17 drug manufacturers outlining steps they must take to bring down prescription drug prices. If they refuse to step up, the Administration will use every tool to protect Americans from continued abusive drug pricing practices. Letter to Eli Lilly: — Rapid Response 47 (@RapidResponse47) July 31, 2025
CNBC
3 hours ago
- CNBC
Microsoft could be due for a big pullback as one of the most overbought names on Wall Street
Stocks that saw gains in recent days could be at risk of sliding, according to one popular technical indicator. Major U.S. indexes tumbled Friday on fears that the economy could be headed toward a slowdown, after July's jobs data came out far weaker than expected and President Donald Trump rolled out modified tariff rates . This week, the S & P 500 lost about 2.4%, while the tech-heavy Nasdaq Composite tumbled 2.2%. The Dow Jones Industrial Average shed 2.9%. After this week's rocky performance, CNBC Pro used its Stock Screener tool to identify the market's most overbought and oversold stocks this past week based on their 14-day relative strength index, or RSI. A stock with an RSI reading above 70 can suggest it could be overbought and may see a dip in the near term. On the other hand, an RSI below 30 indicates a stock is oversold and could see gains ahead. Take a look at Wall Street's most overbought names below: Microsoft shares jumped after the software giant posted strong earnings and revenue for its fiscal fourth quarter, briefly putting the company's market cap above $4 trillion. Microsoft reported revenue from its Azure business and other cloud services for the first time, with sales exceeding $75 billion for fiscal year 2025, up 34% from the prior year. Shares of Microsoft gained 2% this week. The stock has an RSI of 78.4, making it one of the most overbought on the list. Analysts from Goldman Sachs and Bank of America lifted their price targets on Microsoft after its financial results. Defense and aerospace company Northrop Grumman made the overbought list with an RSI of 76.1. Shares rose 1.7% on Friday, defying much of the broader market's moves and touching an all-time high. The stock advanced 2.9% this week. Northrop, up nearly 25% in 2025, is benefiting from increased global defense funding and geopolitical tensions . Half of the 24 analysts covering Northrop Grumman have either a strong buy or buy rating on the stock, while the remaining 12 rate it a hold, according to LSEG. Power generation products maker Generac and data storage company Western Digital are other overbought names this week, with respective RSIs of 79.1 and 74.2. Meanwhile, take a look at the most oversold companies: Health care giants Centene and Molina Healthcare could see upside after getting battered this week. Shares of Centene, which has an RSI of 23.1, lost 8.7% this week. The managed care company's surprise second-quarter adjusted loss weighed on the stock. Molina Healthcare, with an RSI of 22.8, dropped about 6% this week. Other oversold names are Charter Communications , industrial supply company W.W. Grainger and research firm Gartner .
